PIPA: Combination of PI3 Kinase Inhibitors and PAlbociclib

NCT02389842 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
79
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Royal Marsden NHS Foundation Trust

Collaborators